News | Artificial Intelligence | November 26, 2020

Study conducted by medical AI startup Lunit and Massachusetts General Hospital, published in JAMA Network Open - When used as a second reader, the AI algorithm may help detect lung cancer

Study conducted by medical AI startup Lunit and Massachusetts General Hospital, published in JAMA Network Open - When used as a second reader, the AI algorithm may help detect lung cancer

November 26, 2020 — A recent study published in JAMA Network Open has shown that an AI algorithm trained to detect pulmonary nodules can improve lung cancer detection on chest radiographs.

The study was conducted by MGH and Lunit, a South Korean medical artificial intelligence (AI) company. The joint research team analyzed 5,485 chest radiographs collected from participants in the National Lung Screening Trial (NLST) with Lunit INSIGHT CXR, an AI software for diagnosing chest x-rays.

According to this diagnostic study, the sensitivity and specificity of the AI algorithm for finding malignant pulmonary nodules were 94% and 83%, respectively. It even had a higher sensitivity compared to NLST radiologists, implementing its possibility to help detect lung cancer when used as a second reader.

“Low-dose CT is recommended for lung cancer screening because the detection of chest radiographs is challenging for radiologists due to its projectional nature of radiography,” explained Subba Digumarthy, the senior author of the study and an attending thoracic radiologist at MGH. “However, compared with chest radiography, CT is less accessible and more expensive, exposing patients to a higher dose of radiation. This study shows that AI can provide diagnostic value to more patients by supplementing the shortcomings and maintaining the advantages of x-ray diagnosis.”

“Through this first collaboration with the MGH research team, we are happy to validate the generalizability and accuracy of our AI approach based on NLST data,” said Brandon Suh, CEO of Lunit. “It is a meaningful study to show Lunit INSIGHT CXR can be utilized to diagnose cancer-related nodules and detect lung cancer in earlier stages.”

Lunit Insight CXR analyzes more than 3 million images in more than 80 countries, and has an accuracy of 97 to 99% in detecting 10 major chest diseases such as lung nodules and pneumothorax. It is CE marked and clinically available in Europe.

For more information: www.lunit.io


Related Content

News | Digital Radiography (DR)

July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR ...

Time July 10, 2025
arrow
News | Prostate Cancer

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time July 09, 2025
arrow
News | Computed Tomography (CT)

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University ...

Time July 03, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise[1] MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
Subscribe Now